Xtane Tablet (Exemestane 25mg)

What is Xtane Tablet (Exemestane 25mg)?

Xtane Tablet (Exemestane 25mg) is a prescription oral medication classified as an irreversible aromatase inhibitor. It is primarily prescribed to postmenopausal women with hormone receptor-positive early or advanced breast cancer. By inhibiting the enzyme aromatase, Exemestane reduces the body's estrogen production, which can slow or stop the growth of certain breast tumors that depend on estrogen to proliferate. It is typically used after initial treatment with tamoxifen or as upfront therapy in appropriate patients.

Key features

• Active Ingredient — Exemestane 25mg per tablet, a steroidal aromatase inhibitor.
• Prescription Required — Not available over-the-counter; must be used under medical supervision.
• Dosing — Typically taken once daily, preferably after a meal.
• Targeted Therapy — Specifically designed for hormone-sensitive breast cancer in postmenopausal women.
• Proven Efficacy — Clinically shown to reduce recurrence risk in early-stage breast cancer.
• Storage — Store at room temperature, away from moisture and light.
• Manufacturer — Marketed under the brand name Xtane; generic versions may vary.

Who is Xtane Tablet (Exemestane 25mg) for?

This medication is intended for postmenopausal women diagnosed with estrogen receptor-positive breast cancer. It is commonly prescribed after 2–3 years of tamoxifen therapy or as initial endocrine treatment. It is not suitable for premenopausal women or those with known hypersensitivity to exemestane. Patients with severe liver or kidney impairment should consult their physician before use.

How does Xtane Tablet (Exemestane 25mg) compare?

Compared to non-steroidal aromatase inhibitors like anastrozole and letrozole, Xtane is a steroidal inhibitor with irreversible action, potentially offering a different side effect profile. It may be preferred in patients who experience joint pain or musculoskeletal symptoms with other aromatase inhibitors. Unlike tamoxifen, which is a selective estrogen receptor modulator (SERM), Xtane reduces systemic estrogen levels, making it more effective in postmenopausal women. However, it is not interchangeable without medical guidance.